267 Effects of tolvaptan on physician‐assessed signs and symptoms in patients admitted with acute heart failure ‐ results from the EVEREST program

267 Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure results from the EVEREST program M. Gheorghiade1, P. Pang1, J. Blair1, K. Swedberg2, F. Zannad3, A. Maggioni4, L. Grinfield5, J. Burnett6, C. Zimmer7, M. Konstam8 1Northwestern University, Internal Medicine/Cardiology, Chicago, United States of America; 2Sahlgrenska University Hospital, Gothenburg, Sweden; 3INSERM, Nancy, France; 4Associazione Nazionale Medici Cardioligi, Florence, Italy; 5Hospital Italiano, Buenos Aires, Argentina; 6Mayo Medical School, Rochester, United States of America; 7Otsuka Maryland Research Institute, Rockville, United States of America; 8Tufts Universtiy New England Medical Center, Boston, United States of America